Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04814732
Title Expanded Access Program of Surufatinib
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications

neuroendocrine tumor

Therapies

Surufatinib

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.